# Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease

> **NCT01834079** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chaitanya Hospital, Pune** · enrollment: 24 (estimated)

## Conditions studied

- Optic Atrophy

## Interventions

- **BIOLOGICAL:** STEM CELL THERAPY

## Key facts

- **NCT ID:** NCT01834079
- **Lead sponsor:** Chaitanya Hospital, Pune
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01834079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01834079, "Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01834079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*